Ostfold Hospital Trust
so-hf.noTotal trials
50
Active
12
Phase 3
5
Total enrollment
42,141
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Rituximab | — | — | — | — | — | 3 | |
| Avatrombopag | — | — | — | — | — | 1 |
Next readouts
- 2028-01-31
Top conditions
- Ankle Fractures4
- Pain, Postoperative3
- Hallux Valgus2
- Attention Deficit Hyperactivity Disorder2
- Quality of Life2
- Deltoid Ligament; Sprain (Strain) (Ankle)2
- Fecal Incontinence2
- Urinary Incontinence2
Frequently asked questions about Ostfold Hospital Trust
- How many clinical trials does Ostfold Hospital Trust have on ClinicalTrials.gov?
- Ostfold Hospital Trust is listed as the lead sponsor on 50 clinical trials in ClinicalTrials.gov, 12 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Ostfold Hospital Trust's trials are in Phase 3?
- 5 of Ostfold Hospital Trust's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Ostfold Hospital Trust focus on?
- Ostfold Hospital Trust's most-studied conditions on ClinicalTrials.gov are Ankle Fractures, Pain, Postoperative, Hallux Valgus, Attention Deficit Hyperactivity Disorder, Quality of Life.
- When are Ostfold Hospital Trust's next clinical trial readouts?
- Ostfold Hospital Trust has 1 upcoming primary-completion readout tracked here; the soonest is “The Holistic Study”, expected around 2028-01-31.